Ionis Pharmaceuticals, Inc.
IONSNASDAQHealthcare● Active
$74.48
$-0.65(-0.87%)
Market Cap$12.3B
P/E Ratio—
52W High$86.74
52W Low$34.78
Ionis Pharmaceuticals, Inc.（IONS）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IONS · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.94B | $0.71B | $0.79B | $0.59B | $0.81B |
| Cost of Revenue | $0.02B | $0.01B | $0.01B | $0.01B | $0.01B |
| Gross Profit | $0.93B | $0.69B | $0.78B | $0.57B | $0.80B |
| Gross Margin %(computed) | 98.31% | 98.41% | 98.84% | 97.60% | 98.66% |
| Operating Expenses | |||||
| R&D Expenses | $0.92B | $0.90B | $0.90B | $0.83B | $0.64B |
| G&A Expenses | $0.00B | $0.27B | $0.23B | $0.15B | $0.17B |
| Total Operating Expenses | $1.31B | $1.17B | $1.13B | $0.98B | $0.83B |
| Operating Income | ($0.38B) | ($0.48B) | ($0.35B) | ($0.41B) | ($0.03B) |
| Operating Margin %(computed) | -40.47% | -67.37% | -44.91% | -69.84% | -3.72% |
| Interest Income | $0.00B | $0.11B | $0.09B | $0.03B | $0.01B |
| Interest Expense | $0.07B | $0.09B | $0.08B | $0.01B | $0.01B |
| Income Before Tax | ($0.38B) | ($0.46B) | ($0.33B) | ($0.26B) | ($0.03B) |
| Income Tax Expense | $0.00B | ($0.01B) | $0.03B | $0.01B | ($0.00B) |
| Net Income | ($0.38B) | ($0.45B) | ($0.37B) | ($0.27B) | ($0.03B) |
| Net Margin %(computed) | -40.36% | -64.37% | -46.50% | -45.92% | -3.53% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 |
| Wtd Avg Shares | 0.16B | 0.15B | 0.14B | 0.14B | 0.14B |
| EBITDA | ($0.29B) | ($0.35B) | ($0.24B) | ($0.23B) | ($0.01B) |
| EBITDA Margin %(computed) | -30.38% | -50.16% | -29.95% | -38.78% | -0.64% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Ionis Pharmaceuticals, Inc.
关于Ionis Pharmaceuticals, Inc.（IONS）损益表
Ionis Pharmaceuticals, Inc.（IONS）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，IONS实现营收$0.94B，毛利润$0.93B（毛利率98.31%），净利润($0.38B)（净利率-40.36%）。
常见问题
IONS · 4 问Ionis Pharmaceuticals, Inc.（IONS）2025财年营收为$0.94B，同比up33.9%。
IONS revenueIONS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08